The tunicamycins are archetypal nucleoside antibiotics targeting bacterial peptidoglycan biosynthesis and eukaryotic protein N-glycosylation. Understanding the biosynthesis of their unusual carbon framework may lead to variants with improved selectivity. Here, we demonstrate in vitro recapitulation of key sugar-manipulating enzymes from this pathway. TunA is found to exhibit unusual regioselectivity in the reduction of a key α,β-unsaturated ketone. The product of this reaction is shown to be ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Biosynthesis of the tunicamycin antibiotics proceeds via unique exo-glycal intermediates.
If you are the owner of this record, you can report an update to it here: Report update to this record